Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Echo IQASX:EIQ -5.16%22 3-Year EBITDA Growth Rate is -16.30% as of Dec. 2025. GuruFocus rates ASX:EIQ with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 527 Healthcare Providers & Services companies, Echo IQ ranks worse than 86.53% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was -16.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -14.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 26.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Echo IQ was 72.70% per year. The lowest was -65.40% per year. And the median was 4.60% per year.
Echo IQ (ASX:EIQ) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Echo IQ 3-Year EBITDA Growth Rate Related Terms
ASX:EIQ vs VEEV, BTSG, HQY: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Echo IQ's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Echo IQ's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -16.30% mean?
Echo IQ (ASX:EIQ) has a 3-Year EBITDA Growth Rate of -16.30% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Echo IQ and its competitors. According to the industry distribution chart, Echo IQ ranks #456 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 86.5%.
Is Echo IQ's 3-Year EBITDA Growth Rate too high?
Echo IQ's current 3-Year EBITDA Growth Rate is -16.30%. Based on the distribution chart, Echo IQ ranks #456 out of 527 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #456 out of 527 companies for 3-Year EBITDA Growth Rate. This places Echo IQ in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current 3-Year EBITDA Growth Rate is -16.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Echo IQ (ASX:EIQ) has a current 3-Year EBITDA Growth Rate of -16.30%. The current 3-Year EBITDA Growth Rate is -16.30%. Echo IQ's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Echo IQ (ASX:EIQ), the current 3-Year EBITDA Growth Rate is -16.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
22GF Score
Get the complete analysis for ASX:EIQ
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EIQ has been successfully added to your 
